Mukherjee et al., Surgery 2010
(Adenocarcinoma...) :
DARPP-32 expression in AGS cells led to increased protein levels of phospho-AKT and BCL-2 Belkhiri et al., Clin Cancer Res 2012
(Cell Transformation, Neoplastic...) :
DARPP-32 induced BCL-xL expression through activation of Src/STAT3 signaling, and treatment with the Src-specific inhibitor PP1 abrogated DARPP-32 dependent BCL-xL upregulation and cell survival in MKN-28 cells